0001209191-23-012199.txt : 20230223 0001209191-23-012199.hdr.sgml : 20230223 20230223163324 ACCESSION NUMBER: 0001209191-23-012199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230222 FILED AS OF DATE: 20230223 DATE AS OF CHANGE: 20230223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hansen Carl L. G. CENTRAL INDEX KEY: 0001834412 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 23660229 MAIL ADDRESS: STREET 1: C/O ABCELLERA BIOLOGICS INC. STREET 2: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-22 0 0001703057 AbCellera Biologics Inc. ABCL 0001834412 Hansen Carl L. G. C/O ABCELLERA BIOLOGICS INC. 2215 YUKON STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA 1 1 1 0 Chief Executive Officer Common Shares 2023-02-22 4 M 0 56125 2.70 A 505125 D Common Shares 55859493 I See footnote Share option (right to buy) 2.70 2023-02-22 4 M 0 56125 0.00 D 2030-11-18 Common Shares 56125 6557566 D These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person. The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. /s/ Tryn Stimart, attorney-in-fact 2023-02-23